Home › Products › Oncology › Vinelbine 50mg Injection
Vinelbine 50mg Injection
Salt Composition: VINORELBINE
- Manufacturer: FRESENIUS KABI INDIA PVT LTD
- Pack Size: 1 VIAL(s) OF 5ML
- Dosage Form: INJECTION
- Strength: 50MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep Vinelbine 50mg Injection out of sight and reach of children. Store in a refrigerator (2°C to 8°C).
₹7854.00₹17451.56
Inclusive of all taxes
Product Introduction
Vinelbine 50mg Injection is a chemotherapy medication containing the active ingredient Vinorelbine. It is classified as a vinca alkaloid and is indicated for the treatment of non-small cell lung cancer and breast cancer. Cancer occurs when cells multiply in an uncontrolled and abnormal manner. This medication is not recommended for adolescents and children under 18 years of age.
Common side effects associated with Vinelbine 50mg Injection include nausea, vomiting, low blood cell counts, tiredness, weakness, hair loss, pain in the jaws, joints, and muscles, diarrhoea, swelling or sores in the throat or mouth, and injection site reactions such as redness, burning pain, and vein discoloration. Inform your physician if these side effects occur or persist.
Report to your doctor if you are allergic to Vinelbine 50mg Injection or any of its ingredients. While receiving this injection, inform your physician if you experience any signs or symptoms of infection (cough, fever, chills, or joint pain), severe chest pain, have a history of heart attack, or have liver disorders. Your physician will monitor your blood cell count before and during treatment with this medication.
Use effective contraception during treatment and for at least three months after the final dose. Inform your physician about all your medicines, including herbal medicines and supplements. Live attenuated vaccines are not recommended during this treatment. Discuss with your healthcare professional if you have recently received any vaccines or require any vaccinations.
Uses
Non-small cell lung cancer (NSCLC) Breast cancer
How it works
Vinelbine 50mg Injection works by inhibiting the microtubule structures within the cell. Microtubule structures help cancer cells to divide and multiply. Inhibition of these structures slows the growth and multiplication of cancer cells.
How to Use
Vinelbine 50mg Injection is administered into a vein by your healthcare provider. The dose and duration are decided by your physician, depending on the condition. Do not self-administer.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe allergic reactions (rash, difficulty in breathing, swelling of eyelids, lips, face, or throat) Severe chest pain Severe low blood pressure (severe dizziness, lightheadedness when you stand up) Severe constipation with abdominal pain Major infection (cough, fever, chills) Common Nausea, vomiting Low blood cell counts, weakness Hair loss Swelling or sores in the throat or mouth Injection site reactions (redness, burning pain, vein discoloration) Pain in the jaws, joints, and muscles Tiredness Diarrhea
Expert Tips
It is suggested that women should use effective birth control for at least three months before starting and during treatment with Vinelbine 50mg Injection. Male patients are advised to use effective contraception during therapy and three months after treatment to avoid fathering children. Before receiving this Injection treatment, male patients should get advice on sperm conservation. Your doctor may take regular blood tests to monitor your blood cell count, platelet count, and liver function.
References
- Pierre Fabre Limited, Electronic medicines compendium (EMC), [Revised on Nov 2022] [ Accessed on 1st Dec 2022], https://www.medicines.org.uk/emc/files/pil.3912.pdf
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1706.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
- Pierre Fabre Medicament, US Food and Drug administration, [Revised on Jan 2022] [ Accessed on 1st Dec 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020388s037lbl.pdf
- Anna Capasso; Vinorelbine in Cancer therapy; Cancer Drug Targets; Published on July 2012; Accessed on 01/12/2022; https://pubmed.ncbi.nlm.nih.gov/22594474/
- Ying-Chun Xu et al; A systematic review of vinorelbine for the treatment of breast cancer; The Breast Journal; Published on April 2013; Accessed on 01/12/2022; https://pubmed.ncbi.nlm.nih.gov/23320984/
Safety Advice
Pregnancy: unsafe Vinelbine 50mg Injection is unsafe to use during pregnancy as it may harm the unborn baby.
Lungs: Consult your doctor It is unknown whether Vinelbine 50mg Injection can be administered to lung failure patients. Please consult your physician, if you have any lung problems.
Breastfeeding: unsafe It is not recommended for breastfeeding while taking Vinelbine 50mg Injection.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.